Return On Equity of MEDIFAST INC from 30 Jun 2011 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
MEDIFAST INC quarterly and annual Return On Equity in % history and change rate from 30 Jun 2011 to 31 Dec 2025.
- MEDIFAST INC Return On Equity for the quarter ending 31 Dec 2025 was -9%, a 1042% decline year-over-year.
- MEDIFAST INC annual Return On Equity for 2025 was -9%, a 1042% decline from 2024.
- MEDIFAST INC annual Return On Equity for 2024 was 0.96%, a 98% decline from 2023.
- MEDIFAST INC annual Return On Equity for 2023 was 53%, a 40% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
MEDIFAST INC Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -9% | -10% | -1042% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | 0.07% | -3.3% | -98% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | 1.7% | -13% | -88% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -3.4% | -37% | -110% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | 0.96% | -52% | -98% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | 3.4% | -65% | -95% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | 14% | -66% | -82% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | 34% | -60% | -64% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | 53% | -36% | -40% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | 68% | -18% | -21% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | 81% | -3.7% | -4.4% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | 94% | +12% | +15% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | 88% | +3.1% | +3.6% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | 86% | -0.91% | -1% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | 84% | -6% | -6.6% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | 81% | -3.8% | -4.5% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | 85% | +7% | +8.9% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | 87% | +7.2% | +8.9% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | 90% | +22% | +31% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | 85% | +18% | +28% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | 78% | +11% | +17% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | 80% | +17% | +28% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | 69% | +7.7% | +13% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | 67% | +9.1% | +16% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | 67% | +16% | +32% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | 63% | +19% | +44% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | 61% | +24% | +63% | 01 Apr 2019 | 30 Jun 2019 |
| Q1 2019 | 58% | +26% | +85% | 01 Jan 2019 | 31 Mar 2019 |
| Q4 2018 | 51% | +25% | +92% | 01 Oct 2018 | 31 Dec 2018 |
| Q3 2018 | 44% | +20% | +81% | 01 Jul 2018 | 30 Sep 2018 |
| Q2 2018 | 37% | +13% | +54% | 01 Apr 2018 | 30 Jun 2018 |
| Q1 2018 | 31% | +11% | +51% | 01 Jan 2018 | 31 Mar 2018 |
| Q4 2017 | 27% | +7.4% | +38% | 01 Oct 2017 | 31 Dec 2017 |
| Q3 2017 | 24% | +4.8% | +25% | 01 Jul 2017 | 30 Sep 2017 |
| Q2 2017 | 24% | +5.2% | +27% | 01 Apr 2017 | 30 Jun 2017 |
| Q1 2017 | 21% | -1.8% | -8% | 01 Jan 2017 | 31 Mar 2017 |
| Q4 2016 | 19% | -3.8% | -17% | 01 Oct 2016 | 31 Dec 2016 |
| Q3 2016 | 19% | +4.2% | +28% | 01 Jul 2016 | 30 Sep 2016 |
| Q2 2016 | 19% | +4.6% | +32% | 01 Apr 2016 | 30 Jun 2016 |
| Q1 2016 | 22% | +9% | +67% | 01 Jan 2016 | 31 Mar 2016 |
| Q4 2015 | 23% | +8.6% | +60% | 01 Oct 2015 | 31 Dec 2015 |
| Q3 2015 | 15% | -7.7% | -34% | 01 Jul 2015 | 30 Sep 2015 |
| Q2 2015 | 14% | -7.5% | -34% | 01 Apr 2015 | 30 Jun 2015 |
| Q1 2015 | 14% | -9.4% | -41% | 01 Jan 2015 | 31 Mar 2015 |
| Q4 2014 | 14% | -8.9% | -38% | 01 Oct 2014 | 31 Dec 2014 |
| Q3 2014 | 23% | +2.4% | +12% | 01 Jul 2014 | 30 Sep 2014 |
| Q2 2014 | 22% | -1.3% | -5.5% | 01 Apr 2014 | 30 Jun 2014 |
| Q1 2014 | 23% | +2.8% | +14% | 01 Jan 2014 | 31 Mar 2014 |
| Q4 2013 | 23% | +4.4% | +23% | 01 Oct 2013 | 31 Dec 2013 |
| Q3 2013 | 20% | +1.2% | +6.6% | 01 Jul 2013 | 30 Sep 2013 |
| Q2 2013 | 23% | +6% | +35% | 01 Apr 2013 | 30 Jun 2013 |
| Q1 2013 | 20% | -1.7% | -7.7% | 01 Jan 2013 | 31 Mar 2013 |
| Q4 2012 | 19% | -6.3% | -25% | 01 Oct 2012 | 31 Dec 2012 |
| Q3 2012 | 19% | +12% | +169% | 01 Jul 2012 | 30 Sep 2012 |
| Q2 2012 | 17% | +9.2% | +115% | 01 Apr 2012 | 30 Jun 2012 |
| Q1 2012 | 22% | 01 Jan 2012 | 31 Mar 2012 | ||
| Q4 2011 | 25% | 01 Oct 2011 | 31 Dec 2011 | ||
| Q3 2011 | 7.1% | 01 Jul 2011 | 30 Sep 2011 | ||
| Q2 2011 | 8% | 01 Apr 2011 | 30 Jun 2011 |
MEDIFAST INC Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -9% | -10% | -1042% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | 0.96% | -52% | -98% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | 53% | -36% | -40% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | 88% | +3.1% | +3.6% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | 85% | +7% | +8.9% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | 78% | +11% | +17% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | 67% | +16% | +32% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | 51% | +25% | +92% | 01 Jan 2018 | 31 Dec 2018 |
| 2017 | 27% | +7.4% | +38% | 01 Jan 2017 | 31 Dec 2017 |
| 2016 | 19% | -3.8% | -17% | 01 Jan 2016 | 31 Dec 2016 |
| 2015 | 23% | +8.6% | +60% | 01 Jan 2015 | 31 Dec 2015 |
| 2014 | 14% | -8.9% | -38% | 01 Jan 2014 | 31 Dec 2014 |
| 2013 | 23% | +4.4% | +23% | 01 Jan 2013 | 31 Dec 2013 |
| 2012 | 19% | 01 Jan 2012 | 31 Dec 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.